At this time, posts about Myeongmun Pharmaceutical are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net purchased 95,000 shares today. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company specializing in prescription drugs.


As of 11:30 AM on the 6th, Myeongmun Pharmaceutical's stock price is 7,490 KRW, up 1.63% from the previous day, with a trading volume of 11,227,258 shares, which is 50.94% of the average trading volume over the past 5 days. On October 5th, Myeongmun Pharmaceutical became an issue in the market with the news of 'rapid increase... teicoplanin's COVID-19 treatment effect.'


In addition to Myeongmun Pharmaceutical, posts by investors are also surging for NanoEnTek (039860), Korea Technology Group (000240), and SY (109610).



※Source: AI Investment Assistant AI Rassi


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing